New CEO for Lundbeck

Deborah Dunsire, former CEO of Millennium, whose background is primarily in oncology, has been named CEO of Lundbeck, a neuroscience specialist. Lundbeck has been searching for a new CEO since November of last year when Kåre Schultz left for Teva.

While at millennium, Dunshire transformed the company into an oncology biotech leader before it was sold to Takeda. Her new tenure will begin on September 1st.

Click here to read the entire article.